Benzinga | Sep 25, 2020 06:43AM EDT

B. Riley FBR Initiates Coverage On Axcella Health with Buy Rating, Announces Price Target of $14

B. Riley FBR analyst Chad Mabry initiates coverage on Axcella Health (NASDAQ:AXLA) with a Buy rating and announces Price Target of $14.